Classify goitres and management of primary thyrotoxicosis in detail according to standard ENT textbook and in simplified manner

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

classification of goitre thyroid enlargement diagram

This anteroposterior (AP) neck X-ray demonstrates a diagnostic image of severe goitre with extensive dystrophic calcification. The primary finding is a large, dense, radio-opaque mass in the left cervical region, indicated by arrow A, which corresponds to a heavily calcified left thyroid lobe. The mass exhibits a characteristic 'eggshell' or coarse calcification pattern along its periphery. Significant mass effect is evident as the trachea, marked by arrow B, is markedly displaced and deviated toward the right side of the midline. The cervical vertebrae and upper thoracic ribs are visible in the background, providing anatomical context for the degree of tracheal shifting. This image illustrates the clinical consequences of long-standing multinodular goitre, specifically airway compression and deviation caused by calcified thyroid enlargement. It is an educational example for radiology and endocrinology students regarding the evaluation of cervical masses and their impact on adjacent midline structures.

This anteroposterior (AP) neck X-ray demonstrates a diagnostic image of severe goitre with extensive dystrophic calcification. The primary finding is a large, dense, radio-opaque mass in the left cervical region, indicated by arrow A, which corresponds to a heavily calcified left thyroid lobe. The mass exhibits a characteristic 'eggshell' or coarse calcification pattern along its periphery. Significant mass effect is evident as the trachea, marked by arrow B, is markedly displaced and deviated toward the right side of the midline. The cervical vertebrae and upper thoracic ribs are visible in the background, providing anatomical context for the degree of tracheal shifting. This image illustrates the clinical consequences of long-standing multinodular goitre, specifically airway compression and deviation caused by calcified thyroid enlargement. It is an educational example for radiology and endocrinology students regarding the evaluation of cervical masses and their impact on adjacent midline structures.

A clinical photograph of an extirpated gross surgical specimen, identified as a giant goitre (thyroid tumor) following total thyroidectomy. The specimen is a large, multi-nodular, and lobulated mass with an irregular morphology. It exhibits a predominantly dark red and fleshy appearance with variations in tissue color, suggesting heterogeneous vascularization and potentially areas of cystic change or hemorrhage. The surface is moist and glistening with evidence of adherent blood. A medical ruler placed alongside the specimen indicates its significant proportions, measuring approximately 15 cm in length and 13 cm in width, with a total weight of 515 g. This image demonstrates the massive enlargement of thyroid tissue capable of causing severe anatomical displacement, such as tracheal compression and glottic shift, which are critical considerations for anesthetic airway management. The educational focus is on gross pathology of benign thyroid disease and its surgical implications.

A clinical photograph of an extirpated gross surgical specimen, identified as a giant goitre (thyroid tumor) following total thyroidectomy. The specimen is a large, multi-nodular, and lobulated mass with an irregular morphology. It exhibits a predominantly dark red and fleshy appearance with variations in tissue color, suggesting heterogeneous vascularization and potentially areas of cystic change or hemorrhage. The surface is moist and glistening with evidence of adherent blood. A medical ruler placed alongside the specimen indicates its significant proportions, measuring approximately 15 cm in length and 13 cm in width, with a total weight of 515 g. This image demonstrates the massive enlargement of thyroid tissue capable of causing severe anatomical displacement, such as tracheal compression and glottic shift, which are critical considerations for anesthetic airway management. The educational focus is on gross pathology of benign thyroid disease and its surgical implications.

This diagnostic axial contrast-enhanced CT scan of the neck and thoracic outlet demonstrates a significant, asymmetric enlargement of the thyroid gland, indicated by a red arrow. The large thyroid mass predominantly involves the right lobe and exhibits heterogeneous enhancement. It exerts a clear mass effect, resulting in marked lateral deviation of the air-filled trachea toward the left side. Surrounding cervical anatomy is visible, including the cervical vertebrae and major vascular structures such as the carotid arteries and internal jugular veins, which appear in close proximity to the infiltrative mass. The image illustrates the clinical presentation of an invasive cervical process, consistent with pathology such as Riedel's thyroiditis or anaplastic carcinoma. This imaging modality is used to evaluate goitre progression, airway patency, and the involvement of adjacent neurovascular structures in the neck.

This diagnostic axial contrast-enhanced CT scan of the neck and thoracic outlet demonstrates a significant, asymmetric enlargement of the thyroid gland, indicated by a red arrow. The large thyroid mass predominantly involves the right lobe and exhibits heterogeneous enhancement. It exerts a clear mass effect, resulting in marked lateral deviation of the air-filled trachea toward the left side. Surrounding cervical anatomy is visible, including the cervical vertebrae and major vascular structures such as the carotid arteries and internal jugular veins, which appear in close proximity to the infiltrative mass. The image illustrates the clinical presentation of an invasive cervical process, consistent with pathology such as Riedel's thyroiditis or anaplastic carcinoma. This imaging modality is used to evaluate goitre progression, airway patency, and the involvement of adjacent neurovascular structures in the neck.

Searching Images

Graves disease exophthalmos thyrotoxicosis clinical photo

Imaging modality and technique: Clinical frontal photograph of the orbits and periorbital region in a living adult patient. Frontal view capturing both eyes demonstrates bilateral exophthalmos with mild periorbital edema and eyelid swelling. The ocular surfaces are visible with subtle scleral exposure and conjunctival vascularity not markedly prominent in this image. Anatomical localization centers on the orbital contents including extraocular muscles and orbital fat, with involvement of eyelids and periorbital soft tissues. The appearance is most consistent with thyroid ophthalmopathy (Graves’ orbitopathy), a form of autoimmune orbital inflammatory disease associated with hyperthyroidism or autoimmune thyroiditis. Pathophysiology involves infiltration and edema of orbital connective tissues and extraocular muscles, leading to proptosis, lid retraction, diplopia, and possible optic neuropathy in advanced cases. Pathognomonic imaging features in other modalities include enlargement of the rectus muscles, particularly the inferior and medial recti, with sparing of tendons; however this clinical image illustrates recognizable exophthalmos and periorbital edema rather than radiologic details. This image is clinically relevant for education, differential diagnosis, and patient counseling, as well as for correlating with thyroid function testing and orbital imaging when planning management such as immunotherapy, selenium supplementation, or orbital decompression in refractory cases. This photo supports patient diagnosis and monitoring in endocrinology, ophthalmology, and rheumatology contexts.

Imaging modality and technique: Clinical frontal photograph of the orbits and periorbital region in a living adult patient. Frontal view capturing both eyes demonstrates bilateral exophthalmos with mild periorbital edema and eyelid swelling. The ocular surfaces are visible with subtle scleral exposure and conjunctival vascularity not markedly prominent in this image. Anatomical localization centers on the orbital contents including extraocular muscles and orbital fat, with involvement of eyelids and periorbital soft tissues. The appearance is most consistent with thyroid ophthalmopathy (Graves’ orbitopathy), a form of autoimmune orbital inflammatory disease associated with hyperthyroidism or autoimmune thyroiditis. Pathophysiology involves infiltration and edema of orbital connective tissues and extraocular muscles, leading to proptosis, lid retraction, diplopia, and possible optic neuropathy in advanced cases. Pathognomonic imaging features in other modalities include enlargement of the rectus muscles, particularly the inferior and medial recti, with sparing of tendons; however this clinical image illustrates recognizable exophthalmos and periorbital edema rather than radiologic details. This image is clinically relevant for education, differential diagnosis, and patient counseling, as well as for correlating with thyroid function testing and orbital imaging when planning management such as immunotherapy, selenium supplementation, or orbital decompression in refractory cases. This photo supports patient diagnosis and monitoring in endocrinology, ophthalmology, and rheumatology contexts.

Imaging modality and technique: Gross autopsy photograph of the thyroid gland. The view is a frontal, macroscopic examination of the neck showing diffuse enlargement of both lobes with smooth surfaces and no discrete nodules. The tissue is pink to tan with subtle lobular architecture preserved. This gross appearance corresponds to diffuse hyperplasia and hypertrophy of thyroid follicles seen in Graves disease, producing a diffusely enlarged, symmetric goiter. There are no focal masses or inflammatory lesions evident in this specimen. Clinically, Graves disease is an autoimmune thyrotoxicosis characterized by endogenous hyperthyroidism, ophthalmopathy (exophthalmos), and dermopathy; the autopsy image reflects the thyroid component of that syndrome. Pathophysiology involves stimulation by thyroid-stimulating immunoglobulins that drive diffuse follicular hyperplasia and increased thyroid hormone synthesis. The gross findings support laboratory and clinical data such as suppressed TSH and elevated free T4/T3. Epidemiology notes peak incidence in females aged 20–40 years, with female-to-male ratio ≈10:1. This photograph is valuable for teaching gross pathology, correlating macroscopic thyroid changes with endocrinologic manifestations, and differentiating Graves disease from nodular goiters or thyroiditis in educational and research settings. It also highlights the importance of autopsy correlations in endocrine pathology. Educational utility.

Imaging modality and technique: Gross autopsy photograph of the thyroid gland. The view is a frontal, macroscopic examination of the neck showing diffuse enlargement of both lobes with smooth surfaces and no discrete nodules. The tissue is pink to tan with subtle lobular architecture preserved. This gross appearance corresponds to diffuse hyperplasia and hypertrophy of thyroid follicles seen in Graves disease, producing a diffusely enlarged, symmetric goiter. There are no focal masses or inflammatory lesions evident in this specimen. Clinically, Graves disease is an autoimmune thyrotoxicosis characterized by endogenous hyperthyroidism, ophthalmopathy (exophthalmos), and dermopathy; the autopsy image reflects the thyroid component of that syndrome. Pathophysiology involves stimulation by thyroid-stimulating immunoglobulins that drive diffuse follicular hyperplasia and increased thyroid hormone synthesis. The gross findings support laboratory and clinical data such as suppressed TSH and elevated free T4/T3. Epidemiology notes peak incidence in females aged 20–40 years, with female-to-male ratio ≈10:1. This photograph is valuable for teaching gross pathology, correlating macroscopic thyroid changes with endocrinologic manifestations, and differentiating Graves disease from nodular goiters or thyroiditis in educational and research settings. It also highlights the importance of autopsy correlations in endocrine pathology. Educational utility.

This clinical photograph is a high-resolution, lateral oblique view of the periocular region focusing on the right eye (periorbital skin). The image demonstrates marked periorbital edema with pronounced erythema of the eyelids and surrounding cutaneous tissue. The upper and lower eyelids appear swollen and thickened, with subtle skin redundancy. In thyroid-associated ophthalmopathy (Graves' orbitopathy), this presentation reflects inflammatory edema of orbital tissues, increased adipose and extraocular muscle volume, and skin involvement. The visible periorbital edema may precede or accompany exophthalmos, lid retraction, and diplopia; however, soft tissue contour is partially obscured by lighting. The photo lacks palpation data but serves as a qualitative depiction of orbital involvement. Clinically, these features require correlation with systemic thyroid status: hyperthyroidism or euthyroid Graves' disease; presence of TSH receptor autoantibodies; risk of progressive-eye involvement. This image supports differential diagnosis including periorbital cellulitis and dermatitis, but the chronic inflammatory pattern aligns with thyroid eye disease. For diagnostic significance, the image is valuable for medical education, patient counseling, and multidisciplinary planning—endocrinology, ophthalmology, and dermatology collaboration. Potential clinical use cases include screening for orbital involvement in Graves' disease, documenting disease progression, and teaching residents about periorbital edema etiologies and differential diagnoses.

This clinical photograph is a high-resolution, lateral oblique view of the periocular region focusing on the right eye (periorbital skin). The image demonstrates marked periorbital edema with pronounced erythema of the eyelids and surrounding cutaneous tissue. The upper and lower eyelids appear swollen and thickened, with subtle skin redundancy. In thyroid-associated ophthalmopathy (Graves' orbitopathy), this presentation reflects inflammatory edema of orbital tissues, increased adipose and extraocular muscle volume, and skin involvement. The visible periorbital edema may precede or accompany exophthalmos, lid retraction, and diplopia; however, soft tissue contour is partially obscured by lighting. The photo lacks palpation data but serves as a qualitative depiction of orbital involvement. Clinically, these features require correlation with systemic thyroid status: hyperthyroidism or euthyroid Graves' disease; presence of TSH receptor autoantibodies; risk of progressive-eye involvement. This image supports differential diagnosis including periorbital cellulitis and dermatitis, but the chronic inflammatory pattern aligns with thyroid eye disease. For diagnostic significance, the image is valuable for medical education, patient counseling, and multidisciplinary planning—endocrinology, ophthalmology, and dermatology collaboration. Potential clinical use cases include screening for orbital involvement in Graves' disease, documenting disease progression, and teaching residents about periorbital edema etiologies and differential diagnoses.

I now have all the information I need. Let me compile a comprehensive, well-organized answer.

Classification of Goitres and Management of Primary Thyrotoxicosis

Source: Scott-Brown's Otorhinolaryngology Head & Neck Surgery (Vol 1) and Bailey & Love's Short Practice of Surgery (28th Ed.)

PART 1 - WHAT IS A GOITRE?

The term goitre (from Latin guttur = the throat) describes generalised enlargement of the thyroid gland. The normal thyroid is impalpable. A few key terms:
  • Isolated (Solitary) swelling: Discrete nodule in an otherwise impalpable gland
  • Dominant swelling: Discrete nodule in a gland with clinical evidence of generalised abnormality elsewhere

PART 2 - CLASSIFICATION OF GOITRES

Standard Classification (Bailey & Love, Table 55.3)

CategoryTypeSubtypes
Simple Goitre (Euthyroid)Diffuse HyperplasticPhysiological, Pubertal, Pregnancy
Multinodular Goitre-
Toxic GoitreDiffuse ToxicGraves' disease
Toxic Multinodular-
Toxic AdenomaPlummer's disease
NeoplasticBenignFollicular adenoma
MalignantPapillary, Follicular, Medullary, Anaplastic
InflammatoryAutoimmuneChronic lymphocytic thyroiditis, Hashimoto's disease
Granulomatousde Quervain's thyroiditis
FibrosingRiedel's thyroiditis
InfectiveAcute (bacterial/viral), Chronic (TB, syphilitic)
OtherAmyloid

Simplified Memory Aid (by Function)

GOITRE
  │
  ├── EUTHYROID (normal thyroid function)
  │       ├── Diffuse Hyperplastic (simple) → physiological/pubertal/pregnancy
  │       └── Multinodular (colloid degeneration, cysts, adenomas)
  │
  ├── TOXIC (overactive thyroid)
  │       ├── Diffuse Toxic = GRAVES' DISEASE (PRIMARY thyrotoxicosis)
  │       ├── Toxic Multinodular Goitre (SECONDARY thyrotoxicosis)
  │       └── Toxic Adenoma / Plummer's Disease (SECONDARY thyrotoxicosis)
  │
  ├── NEOPLASTIC
  │       ├── Benign (follicular adenoma)
  │       └── Malignant (papillary, follicular, medullary, anaplastic)
  │
  └── INFLAMMATORY
          ├── Hashimoto's (autoimmune)
          ├── de Quervain's (granulomatous/viral)
          └── Riedel's (fibrosing)

A. Simple Goitre (Euthyroid)

Aetiology:
  • TSH stimulation of the thyroid (due to low circulating T3/T4)
  • Most common cause: iodine deficiency (endemic in mountainous regions - Alps, Himalayas, Andes, Rockies; also Derbyshire/Yorkshire in UK)
  • Daily iodine requirement: 0.1-0.15 mg/day
  • Dyshormonogenesis: enzyme defects in thyroid hormone synthesis (sporadic goitre; often familial)
  • Other growth factors (immunoglobulins) also stimulate follicular cell proliferation
Diffuse Hyperplastic Goitre:
  • Seen physiologically in puberty and pregnancy
  • Due to increased demand for thyroid hormone
Multinodular Goitre (MNG):
  • Results from heterogeneous structural/functional response - clones of cells with varying sensitivity to growth stimulation create nodularity
  • Long natural history; may remain euthyroid for years

B. Toxic Goitre (Overactive)

Diffuse Toxic Goitre = Graves' Disease (PRIMARY thyrotoxicosis)

  • Young women (F:M > 5:1), peak incidence in 20s-30s
  • Autoimmune: circulating IgG autoantibodies (TSHR-Ab) against TSH receptor - activate cAMP, mimic TSH effect, stimulate thyroid hormone synthesis
  • Associated with ophthalmopathy, dermopathy (pretibial myxoedema), acropachy
  • 55% have family history of autoimmune endocrine disease
  • Goitre is diffuse, symmetrical; may have a palpable thrill and audible bruit (increased blood flow)
  • Smoking almost doubles the risk; worsens ophthalmopathy

Toxic Multinodular Goitre (SECONDARY thyrotoxicosis)

  • Older patients (elderly); pre-existing nodular goitre present for years before toxicity develops
  • Two or more autonomously functioning nodules secrete excess thyroid hormone
  • May be precipitated by pharmacological iodine (contrast media) via Jod-Basedow effect
  • Hyperfunction less marked than Graves' disease
  • Cardiovascular symptoms predominate: palpitations, AF, tachyarrhythmias
  • May have compressive symptoms: dysphagia, dyspnoea (worsens at night)

Toxic Adenoma / Plummer's Disease (SECONDARY thyrotoxicosis)

  • Single autonomous nodule secreting excess thyroid hormone
  • Usually grows to at least 3 cm before causing overt hyperthyroidism
  • TSH receptor gene mutation in 20-83% of cases (somatic mutations in transmembrane domain)
  • Accounts for ~5% of thyrotoxicosis cases
  • Surrounding normal thyroid is suppressed
  • Radionuclide scan: single "hot spot" with no other visible uptake
  • No eye signs (unlike Graves' disease)

Retrosternal Goitre

  • Arises from slow growth of MNG down into the mediastinum
  • Causes: tracheal compression, dysphagia, airway symptoms
  • 95% can be removed transcervically
  • Requires cross-sectional imaging (CT) preoperatively
  • Sternotomy needed if: malignant disease, posterior mediastinal extension, diameter > thoracic inlet

Multinodular goitre specimen showing massive thyroid enlargement
Giant multinodular goitre specimen post-total thyroidectomy - illustrates the degree of enlargement possible in long-standing MNG

PART 3 - PRIMARY THYROTOXICOSIS (GRAVES' DISEASE) - MANAGEMENT IN DETAIL

Primary thyrotoxicosis = Graves' disease = Diffuse Toxic Goitre
Key principle: Overt hyperthyroidism requires effective therapy in ALL cases to reduce the risk of psychological, cardiovascular, and skeletal sequelae.
Bilateral exophthalmos - classic sign of Graves' ophthalmopathy
Bilateral exophthalmos in Graves' ophthalmopathy - a feature unique to primary (not secondary) thyrotoxicosis

Step 1 - Symptom Control (Immediate)

  • Beta-blockers (propranolol 40 mg TDS or nadolol 320 mg OD): target-organ blockade
    • Propranolol also inhibits peripheral conversion of T4 → T3
    • Rapid clinical response; patient can be "clinically euthyroid" within days
    • Does NOT reduce thyroid hormone synthesis
    • Used as bridge until definitive treatment takes effect

Step 2 - Three Modalities of Definitive Treatment

(Scott-Brown's Table 61.5)
FeatureAntithyroid DrugsRadioiodine (¹³¹I)Surgery
Graves' disease
Toxic nodular disease-
Pregnancy
Children
Significant ophthalmopathy
Definitive treatment-
Non-invasive-
Low cost-
Risk of hypothyroidismLowHighHigh
Worsens ophthalmopathy-✓ (risk)-
Histological diagnosis--
All three modalities are equally effective at reducing thyroid hormone concentration with similar quality-of-life outcomes.

A. Antithyroid Drugs (Thionamides)

Drugs: Carbimazole (preferred in UK/Europe) and Propylthiouracil (PTU)
Mechanism of action:
  • Block synthesis of T4 and T3 by inhibiting thyroperoxidase enzyme
  • Disrupt organification and oxidation of iodide
  • PTU additionally inhibits peripheral T4 → T3 conversion (useful in thyroid storm)
Dosing regimen:
  • Carbimazole 30-40 mg/day initially
  • Once euthyroid (after 8-12 weeks), reduce to 5 mg 8-hourly
  • OR use "Block and Replace" regime: continue high-dose carbimazole (to block T3/T4) + add thyroxine 0.1-0.15 mg/day to prevent hypothyroidism
Duration:
  • Mild cases: 6 months
  • Severe cases: up to 2 years
  • ~30% achieve lasting remission after antithyroid drug course
  • Failure rate is at least 55% (recurrence on stopping drugs)
When NOT to use antithyroid drugs alone for toxic nodule:
  • Antithyroid drugs cannot cure a toxic adenoma - the tissue is autonomous, and recurrence is certain on stopping.
Side effects: Agranulocytosis (rare but serious - warn patients to report sore throat/fever)

B. Radioiodine (¹³¹I)

Mechanism: Destroys thyroid cells → reduces functioning thyroid tissue below critical level (same principle as surgery but non-invasive)
Indications: Graves' disease (first-line in USA), Toxic MNG
Standard practice:
  • Europe: Antithyroid drugs first (under 40 years); radioiodine for relapse
  • USA: Radioiodine is first-line in Graves' disease and toxic MNG
Advantages:
  • No surgery, no prolonged drug therapy
  • Outpatient procedure
  • Cost-effective
Disadvantages / Precautions:
  • Radiation thyroiditis risk (transient worsening)
  • Patient must be quarantined while radiation levels are high
  • Must defer pregnancy (typically for 6 months after treatment)
  • Avoid close physical contact, especially with children
  • Permanent hypothyroidism is the expected outcome (not a complication - acceptable trade-off)
  • May worsen ophthalmopathy - therefore NOT used in significant Graves' ophthalmopathy
Note: A long-term increase in all-cause and vascular mortality after radioiodine has been described - this is attributed to the underlying thyrotoxicosis diagnosis rather than radioiodine itself. Achieving hypothyroidism post-radioiodine actually reduces this risk.

C. Surgery

Indications for Surgery in Primary Thyrotoxicosis:

  • Large goitre (especially with compressive symptoms)
  • Progressive eye signs (ophthalmopathy worsening)
  • Patient refuses radioiodine
  • Pregnancy (second trimester only)
  • Relapse after antithyroid drugs / radioiodine failure
  • Suspected malignancy
  • Patients who prefer definitive cure without radiation

Surgical Options (Table 55.5 - Bailey & Love):

ParameterTotal ThyroidectomySubtotal Thyroidectomy
Control of toxicityImmediateImmediate
Return to euthyroidImmediateVariable (up to 12 months)
Risk of recurrenceNoneUp to 5% (lifelong)
Risk of thyroid failure100%Up to 100% at 30 years
Permanent hypoparathyroidism5%1%
Follow-up requiredMinimalLifelong
Trend: Total/near-total thyroidectomy is now preferred as it eliminates recurrence risk, though it requires lifelong thyroxine replacement.
The Dunhill procedure = Total lobectomy + isthmusectomy + subtotal lobectomy (near-total thyroidectomy).

Preoperative Preparation (MANDATORY before surgery):

Goal: Make patient biochemically euthyroid before operation
Method 1 - Carbimazole:
  • Carbimazole 30-40 mg/day; take 8-12 weeks to achieve euthyroid state
  • Last dose given on evening before surgery
Method 2 - Beta-blockade (rapid preparation):
  • Propranolol 40 mg TDS (up to 80 mg TDS or nadolol 320 mg OD if needed)
  • Acts on target organs (not on the gland itself)
  • Can achieve clinical euthyroid state within days - allows surgery within days rather than weeks
  • Continue until 7-10 days post-operatively (to prevent rebound sympathetic surge)
Lugol's Iodine (potassium iodide):
  • Given preoperatively in some centres to reduce vascularity of the gland
  • Given for 10 days pre-surgery
  • Cannot be used alone (not a treatment, only an adjunct)

Special Situation: Thyroid Eye Disease in Graves'

  • Mild-to-moderate ophthalmopathy: often needs no treatment; may improve spontaneously
  • Local discomfort: artificial tears, elevate head of bed (to reduce oedema)
  • Severe ophthalmopathy: multidisciplinary team management with ophthalmologists
    • High-dose glucocorticoids ± other immunosuppressants
    • Orbital radiotherapy
    • Rituximab (anti-CD20, depletes B-cells) - evidence emerging
    • Surgical orbital decompression for compressive optic neuropathy
Indications for orbital decompression:
  • Rapid deterioration in visual acuity
  • Ocular nerve palsies
  • Unacceptable cosmetic appearance
  • Visual acuity < 6/18
  • Decreased colour vision
  • Corneal ulceration

PART 4 - QUICK SUMMARY TABLE (Primary vs Secondary Thyrotoxicosis)

FeaturePrimary (Graves')Secondary (Toxic MNG / Adenoma)
CauseAutoimmune (TSHR-Ab)Autonomous nodule(s)
AgeYoung women (20s-30s)Middle-aged / elderly
Goitre typeDiffuse, smooth, vascularNodular
Eye signsPresent (50%)Absent
Onset of goitreSimultaneous with toxicityGoitre long before toxicity
Bruit/thrillPresentAbsent
SeverityMore severeLess severe (especially in MNG)
Predominant symptomsFull thyrotoxic pictureCardiovascular (AF, palpitations)
RadioiodineUsed (caution with eye disease)Preferred definitive treatment
SurgeryAfter antithyroid drugs / relapseOften first-line for large MNG

Sources:
  • Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol 1 - Chapter 61 (Thyroid disorders), Table 61.5, Box 61.4
  • Bailey & Love's Short Practice of Surgery, 28th Ed. - Chapter 55, Table 55.3, Table 55.5

Solitary thyroid nodule, Robotic assisted thyroid surgery, minimally invasive thyroid surgery in detail according to standard ENT textbook

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

robotic thyroid surgery transaxillary da Vinci

This composite of six intraoperative clinical photographs (A–F) demonstrates a 'two-step retraction' operative procedure for robotic transaxillary thyroidectomy using the da Vinci SP system. A-B: The initial stages show the surgical console view following the first docking, where a narrow skin flap is created and widened using a specialized Chung’s retractor and robotic graspers. C: Robotic instruments are seen dissecting and creating a working space between the sternal and clavicular heads of the sternocleidomastoid (SCM) muscle. D: Deeper dissection reveals the thyroid gland situated beneath the strap muscles. E-F: These frames illustrate the 'second docking' or redocking phase, where the retractor is repositioned deeper (beneath the strap muscles) to optimize the spherical working space for the robotic arms. The series highlights the progression from superficial flap dissection to deep anatomical exposure of the thyroid, emphasizing the minimally invasive approach through a single axillary incision and the specialized manipulation of neck musculature to achieve surgical access.

This composite of six intraoperative clinical photographs (A–F) demonstrates a 'two-step retraction' operative procedure for robotic transaxillary thyroidectomy using the da Vinci SP system. A-B: The initial stages show the surgical console view following the first docking, where a narrow skin flap is created and widened using a specialized Chung’s retractor and robotic graspers. C: Robotic instruments are seen dissecting and creating a working space between the sternal and clavicular heads of the sternocleidomastoid (SCM) muscle. D: Deeper dissection reveals the thyroid gland situated beneath the strap muscles. E-F: These frames illustrate the 'second docking' or redocking phase, where the retractor is repositioned deeper (beneath the strap muscles) to optimize the spherical working space for the robotic arms. The series highlights the progression from superficial flap dissection to deep anatomical exposure of the thyroid, emphasizing the minimally invasive approach through a single axillary incision and the specialized manipulation of neck musculature to achieve surgical access.

This clinical photograph set (Figures 4A and 4B) illustrates a comparison of skin flap dissection areas for robotic transaxillary thyroidectomy. The images show a patient in a supine position with surgical markings. In Figure 4A, a 'conventional skin flap' (purple) is depicted as a large, trapezoidal area extending from the axilla across the upper chest toward the sternal notch and lower neck. Overlaid on this is the 'SP (Single Port) skin flap before the 1st docking' (orange), which is significantly narrower and confined to a direct path from the axilla to the midline. Figure 4B demonstrates the 'widened SP skin flap after docking' (pink), showing a triangular expansion toward the superior neck and thyroid region compared to the initial orange tract. The series highlights the technical advancement of the da Vinci SP system, which allows for a more targeted, minimally invasive dissection compared to traditional robotic thyroidectomy approaches. The anatomical focus is the pectoralis major surface, sternocleidomastoid muscle, and the surgical access pathway from the axilla to the thyroid gland.

This clinical photograph set (Figures 4A and 4B) illustrates a comparison of skin flap dissection areas for robotic transaxillary thyroidectomy. The images show a patient in a supine position with surgical markings. In Figure 4A, a 'conventional skin flap' (purple) is depicted as a large, trapezoidal area extending from the axilla across the upper chest toward the sternal notch and lower neck. Overlaid on this is the 'SP (Single Port) skin flap before the 1st docking' (orange), which is significantly narrower and confined to a direct path from the axilla to the midline. Figure 4B demonstrates the 'widened SP skin flap after docking' (pink), showing a triangular expansion toward the superior neck and thyroid region compared to the initial orange tract. The series highlights the technical advancement of the da Vinci SP system, which allows for a more targeted, minimally invasive dissection compared to traditional robotic thyroidectomy approaches. The anatomical focus is the pectoralis major surface, sternocleidomastoid muscle, and the surgical access pathway from the axilla to the thyroid gland.

Searching Images

thyroid nodule ultrasound fine needle aspiration cytology

This dual-panel diagnostic image displays high-resolution ultrasound views of the thyroid gland, illustrating the procedure for ultrasound-guided Fine-Needle Aspiration Cytology (FNAC). Panel A shows a transverse ultrasound view of the right thyroid lobe containing a suspicious nodule marked with a yellow arrow. The nodule is roughly circular with heterogeneous echogenicity and irregular internal margins, categorized clinically as TI-RADS 4, indicating a moderate suspicion of malignancy. Panel B demonstrates the procedural phase, where a 21-gauge biopsy needle (red arrow) is visualized as a linear hyperechoic structure. The needle is shown utilizing a trans-isthmic approach at a shallow angle to accurately target the center of the hypoechoic nodule. These images serve as an educational resource for interventional endocrinology and radiology, highlighting the importance of real-time needle visualization during biopsy to ensure diagnostic accuracy and safety in managing potentially malignant thyroid lesions.

This dual-panel diagnostic image displays high-resolution ultrasound views of the thyroid gland, illustrating the procedure for ultrasound-guided Fine-Needle Aspiration Cytology (FNAC). Panel A shows a transverse ultrasound view of the right thyroid lobe containing a suspicious nodule marked with a yellow arrow. The nodule is roughly circular with heterogeneous echogenicity and irregular internal margins, categorized clinically as TI-RADS 4, indicating a moderate suspicion of malignancy. Panel B demonstrates the procedural phase, where a 21-gauge biopsy needle (red arrow) is visualized as a linear hyperechoic structure. The needle is shown utilizing a trans-isthmic approach at a shallow angle to accurately target the center of the hypoechoic nodule. These images serve as an educational resource for interventional endocrinology and radiology, highlighting the importance of real-time needle visualization during biopsy to ensure diagnostic accuracy and safety in managing potentially malignant thyroid lesions.

This diagnostic ultrasound image in the transverse plane demonstrates a Fine Needle Aspiration Biopsy (FNAB) of a thyroid nodule. The nodule, labeled 'T', presents as a well-defined structure with heterogeneous echogenicity, appearing predominantly hypoechoic compared to the surrounding isoechoic thyroid parenchyma. A biopsy needle, indicated by a white arrow, is visualized as a highly echogenic (bright) linear structure. The needle is shown using an in-plane approach, where it is positioned parallel to the long axis of the ultrasound probe, allowing for continuous visualization of the needle shaft and tip as it enters the nodule. In the lateral aspect of the thyroid lobe, a prominent anechoic (black) circular structure represents a major neck vessel, likely the carotid artery or internal jugular vein. Superficial to the thyroid, the strap muscles are visible as stratified, hypoechoic bands. This image serves as a clinical example of real-time ultrasound guidance to ensure precise needle placement and adequate tissue sampling in the evaluation of thyroid pathology.

This diagnostic ultrasound image in the transverse plane demonstrates a Fine Needle Aspiration Biopsy (FNAB) of a thyroid nodule. The nodule, labeled 'T', presents as a well-defined structure with heterogeneous echogenicity, appearing predominantly hypoechoic compared to the surrounding isoechoic thyroid parenchyma. A biopsy needle, indicated by a white arrow, is visualized as a highly echogenic (bright) linear structure. The needle is shown using an in-plane approach, where it is positioned parallel to the long axis of the ultrasound probe, allowing for continuous visualization of the needle shaft and tip as it enters the nodule. In the lateral aspect of the thyroid lobe, a prominent anechoic (black) circular structure represents a major neck vessel, likely the carotid artery or internal jugular vein. Superficial to the thyroid, the strap muscles are visible as stratified, hypoechoic bands. This image serves as a clinical example of real-time ultrasound guidance to ensure precise needle placement and adequate tissue sampling in the evaluation of thyroid pathology.

I now have comprehensive material from all three major ENT/surgery textbooks. Let me compile the complete answer.

Solitary Thyroid Nodule, Robotic-Assisted Thyroid Surgery, and Minimally Invasive Thyroid Surgery

Sources: Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol 1 (Chapter 69), Cummings Otolaryngology Head and Neck Surgery (Chapter 122), Bailey & Love's Short Practice of Surgery 28th Ed. (Chapter 55)

PART 1 - SOLITARY THYROID NODULE (STN)

Definition and Epidemiology

A solitary (isolated) thyroid nodule is a discrete swelling in an otherwise impalpable thyroid gland. If a similar discrete swelling is found in a gland with clinical evidence of generalised abnormality (palpable contralateral lobe or nodularity), it is called a dominant nodule.
  • Palpable in 3-4% of the adult population in the UK and USA
  • Three to four times more frequent in women than men
  • ~70% of discrete swellings are clinically isolated; ~30% are dominant
  • Ultrasonography and post-mortem studies detect far more nodules than clinical palpation (nodule prevalence rises with age)

Importance - Risk of Malignancy

Type of SwellingRisk of MalignancyRisk of Follicular Adenoma
Truly isolated nodule15%30-40%
Dominant nodule~7-8% (half of isolated)Still substantial
RemainderNon-neoplastic (colloid, cysts, thyroiditis)-
The significance of a solitary nodule lies primarily in ruling out malignancy.

Clinical Assessment - History and Examination

High-risk features suggesting malignancy:
  • Young age (especially children) or elderly males
  • History of radiation exposure to head/neck (especially in childhood)
  • Rapid nodule growth
  • Dysphagia, dysphonia, dyspnoea (upper aerodigestive tract symptoms)
  • Fixation of the nodule (tethered to surrounding structures)
  • Hard, irregular, non-tender consistency
  • Cervical lymphadenopathy
  • Family history of medullary thyroid cancer or MEN-2
Features suggesting benignity:
  • Smooth, soft, mobile nodule
  • Tenderness (suggests thyroiditis or haemorrhage into cyst)
  • Long-standing, slowly growing lesion

Investigation of Solitary Thyroid Nodule

Step 1 - Thyroid Function Tests (TSH)

  • TSH is the initial screening test
  • Hypothyroidism/hyperthyroidism shifts workup away from malignancy toward functional disorders
  • Suppressed TSH - radionuclide scan to rule out toxic hot nodule, Marine-Lenhart syndrome, or Graves' disease with concurrent cold nodule
  • Elevated TSH - treat hypothyroidism, then perform FNAC
  • Normal TSH (most patients) - proceed to FNAC
Note: Thyroglobulin (Tg) is NOT recommended routinely for a thyroid nodule (cannot differentiate benign from malignant). Calcitonin is measured only if family history of MTC or MEN-2.

Step 2 - Autoantibody Titres

  • Raised anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies suggest Hashimoto's thyroiditis

Step 3 - Fine-Needle Aspiration Cytology (FNAC)

FNAC is the procedure of choice - minimally invasive, quick, low complication rate. FNAC has:
  • Reduced the number of patients requiring surgery by 35-75%
  • Almost tripled the yield of malignancies in patients going to surgery
  • Accuracy for papillary carcinoma: 99% with a false-positive rate of <1%
FNAC Result Categories (UK - Thy Classification):
GradeMeaningMalignancy RiskAction
Thy 1Non-diagnostic-Repeat FNAC
Thy 1cNon-diagnostic (cystic)-Repeat/US-guided FNAC
Thy 2Non-neoplastic / Benign1-6% (false negative)Observe; surgery only for symptoms/growth
Thy 3Follicular / Indeterminate~20%Surgery (diagnostic hemithyroidectomy)
Thy 4Suspicious of malignancy-Surgery
Thy 5Malignant-Surgery
Bethesda System (US equivalent - 6 categories, same principle)
  • ~15% of aspirates are non-diagnostic (from cystic, haemorrhagic, hypervascular or hypocellular colloid nodules) - repeat FNAC is mandatory; a non-diagnostic result must NEVER be interpreted as negative for cancer
  • Surgical diagnoses after repeated non-diagnostic aspirations revealed malignancy in 4% of women and 29% of men
Follicular neoplasm caveat: FNAC cannot distinguish follicular adenoma from follicular carcinoma - this requires histological evidence of capsular or vascular invasion on the whole excised specimen. Therefore all follicular neoplasms on FNAC require surgery.

Step 4 - Ultrasonography

  • Most valuable initial imaging; non-invasive and inexpensive
  • Differentiates cystic from solid nodules
  • Detects non-palpable nodules
  • Identifies malignant US features: solid hypoechoic appearance, ill-defined margins, taller-than-wide shape, microcalcifications - all suggest papillary thyroid cancer (NPV 97%)
  • Well-defined hyperechoic nodules with peripheral halo = likely follicular lesion
  • Abnormal neck nodes (cystic or with microcalcification) - raise suspicion for thyroid cancer
  • Guides FNA of non-palpable nodules and improves yield
Ultrasound-guided FNAC of a suspicious thyroid nodule (TI-RADS 4)
Ultrasound-guided FNAC with needle visualized in-plane targeting the hypoechoic nodule

Step 5 - Isotope Scanning (Radionuclide Scan)

  • Indicated when TSH is suppressed (to localise hyperfunction)
  • Hot nodule = functioning autonomously - low malignancy risk
  • Cold nodule = does not take up isotope - higher malignancy risk; if FNAC shows follicular neoplasm + cold nodule on scan, surgery is indicated
  • Replaced to a large extent by USS in routine evaluation

Step 6 - Molecular Marker Testing (for Indeterminate FNAC)

  • Used for Thy3/indeterminate cytology
  • Afirma Gene Expression Classifier: sensitivity 92%, NPV 93% (excellent rule-out test)
  • ThyroSeq: good rule-in test (mutations in BRAF, RAS, RET/PTC, etc.)
  • ThyGenX/ThyraMIR and Rosetta GX Reveal: less published data

Management Algorithm (Cummings Chapter 122)

Thyroid Nodule Discovered
         │
         ▼
History + Physical Exam
(High-risk features → Consider direct surgery)
         │
         ▼
TSH Level
 ┌───────┴───────────────────────┐
 │                               │
Suppressed TSH               Normal/High TSH
     │                           │
Radionuclide scan            FNAC ± Ultrasound
     │                           │
 Hot nodule = treat        ┌─────┴──────────────────────┐
 toxicity                  │                            │
 Cold nodule = FNAC    Benign (Thy2)           Follicular/Susp/Malignant
                           │                    (Thy3/4/5)
                        Observe                    Surgery
                 (surgery if symptoms/growth)

PART 2 - MINIMALLY INVASIVE THYROID SURGERY (MIVAT/MIT)

Source: Scott-Brown's Chapter 69 (Neil S. Tolley)

Introduction and Rationale

  • Kocher's principles of thyroid surgery (early 20th century) remained unchanged for decades
  • 71% of patients surveyed in a thyroid clinic would prefer not to have a neck scar (independent of sex and skin colour)
  • Professionals consistently rate the aesthetics of a thyroid scar more favourably than patients themselves do
  • Technological advances in endoscopes and energy-sealing devices enabled small-incision techniques

Types of Minimally Invasive Thyroid Surgery

There are several techniques, known by various names:
  • MIVAT (Minimally Invasive Video-Assisted Thyroidectomy) = Miccoli technique
  • MIT (Minimally Invasive Thyroidectomy)
  • EAT (Endoscopic-Assisted Thyroidectomy)
  • Henry technique (insufflation method)
"Endoscopic-assisted thyroidectomy" most accurately describes all these in practice.

A. Miccoli Technique (MIVAT)

Pioneered by: Paolo Miccoli, Pisa, Italy
Approach: Gas-less, open method
Incision: 2-3 cm midline incision (vs. standard ~5-8 cm)
Technique:
  1. 2-3 cm midline incision facilitates endoscopic dissection of the superior pole
  2. Superior pole delivered into the neck via the incision
  3. Lower pole dissection and completion thyroidectomy done conventionally once gland is delivered
  4. Uses a 30-degree 4 mm endoscope
  5. Requires specialised instruments: suction dissectors, spatulas, specially designed retractors
  6. Needs two competent assistants and video stacks
Advantages:
  • Excellent visualization of recurrent laryngeal nerve, external laryngeal nerve, and parathyroids
  • No insufflation required (avoids CO2 complications)
  • Can perform total thyroidectomy through a single incision
  • Superior cosmetic outcome (meta-analysis evidence)
Indications (strict criteria):
  • Solitary nodules up to 3 cm
  • Total thyroid lobe volume ≤ 20 mL (equating to 14 mL nodule volume)
  • Extended by experienced surgeons to: selected Graves' disease, selected thyroid cancer patients
Contraindications:
  • History of thyroiditis
  • Cancer (except by highly skilled surgeons)
  • Previous surgery (adhesions)
  • Nodules > 3 cm
Learning curve and volume:
  • Requires >50 cases before expert status is reached
  • Only applicable to ~8% of a UK surgeon's thyroid practice
  • 86% of BAETS (British Association of Endocrine and Thyroid Surgeons) members perform fewer than 50 thyroidectomies per year - explaining why few centres in the UK have adopted this
  • Meta-analysis (Radford, 2011): 318 patients, complications no higher, superior cosmetic outcomes, at the expense of operative time. Scar cosmesis studied only in early post-operative period.
Caution: Small incision may necessitate excessive traction, predisposing to hyperpigmentation and hypertrophy of the scar - the very problem the technique aims to avoid.

B. Henry Technique (Insufflation Method)

Pioneered by: Jean-François Henry, Marseille, France
Approach: Endoscopic with CO2 insufflation
Port placement: Three lateral ports along anterior border of sternomastoid:
  • Two 3 mm ports for instrumentation
  • One 1 cm port for the insufflator endoscope
CO2 pressure: 8 mmHg - creates working space and a bloodless field
Technique:
  • Dissection occurs completely within the neck
  • Delivery of the thyroid lobe through the endoscope port on completion
  • Requires an assistant to hold and manipulate the endoscope
Limitations:
  • Total thyroidectomy is NOT possible by this method
  • Technically much more challenging than Miccoli method
  • Better suited to parathyroidectomy than thyroidectomy
  • CO2 insufflation risk: hypercarbia (potentially serious complication)
  • Not widely adopted for thyroid surgery
Evidence base:
  • Long-term scar satisfaction comparison with conventional thyroidectomy shows little or no difference at 18 months after full healing (personal communication, JFH)

C. Scarless-in-the-Neck Techniques

These are distinct from minimally invasive (which still leave a neck scar, just smaller). These techniques move the incision entirely away from the neck.
Approaches:
  • Transaxillary approach (incision in axilla)
  • ABBA - Axillo-Bilateral-Breast Approach
  • BABA - Bilateral Axillo-Breast Approach
  • Facelift approach (incision behind the ear)
Pioneered by: Japanese and Korean surgeons (driven by cultural aversion to neck scars - horizontal scar in the neck has negative feng shui connotations denoting death)
Techniques use: both gasless and insufflation methods (latter carries hypercarbia risk)
Evidence: Literature shows lobectomy and total thyroidectomy can be achieved safely, though with a steep learning curve and the requirement for a competent assistant working in a confined operative space with a 2D view.

PART 3 - ROBOTIC-ASSISTED THYROIDECTOMY (RAT)

Source: Scott-Brown's Chapter 69 - Neil S. Tolley

Historical Background and Rationale

  • Da Vinci telerobot introduced in the late 1990s
  • Originally conceived by NASA (remote surgery for astronauts) and the Ministry of Defence (bringing surgical expertise to the front line without endangering the surgeon)
  • Patents acquired by Intuitive Surgical, Sunnyvale, California
  • Feasibility of transatlantic surgery demonstrated by Marescaux et al. (2001)
  • First lobectomy using da Vinci with insufflation: Lobe et al. (2005)
  • Current transaxillary technique pioneered by Chung and colleagues, Yonsei University, Seoul - by 2013 they had experience with >3,000 patients

The Da Vinci Robotic System

Three components:
  1. Surgeon Console - surgeon sits here remotely, controls all movements (master-slave system)
  2. Surgical Cart - docked with the patient; has four arms:
    • One holding the stereoscopic 3D endoscope (8 mm or 12 mm)
    • Three arms holding surgical instruments (right hand, left hand, assistant/retractor arm)
  3. Video Stack - containing camera control units (CCDs) and hardware
Key advantages over standard endoscopic surgery:
  • 3D stereoscopic vision (two endoscopes within the casing replicate true 3D - gives depth of field)
  • Magnified view
  • Endoscope can be moved to alter magnification and avoid line-of-sight conflicts
  • 7 degrees of freedom for instrument movement (wristed instruments that replicate hand and wrist movement)
  • Tremor filtration (smooths out natural hand tremor)
  • Surgeon is seated in an ergonomic console
5 iterations: Standard → S → Si → Xi → SP (Single Port) machines

Indications for RAT (Transaxillary Approach)

The ideal patient for RAT (per Scott-Brown's):
  • Thin, narrow-chested female (body habitus important)
  • Thyroid nodule up to 4 cm (hemithyroidectomy); nodules up to 6 cm can be handled by experienced surgeons
  • Total thyroidectomy provided the contralateral lobe is "near normal"
  • Patients with history of hypertrophic scarring or keloid tendency (valid reason to avoid neck scar)
  • Personal preference to avoid neck scar
  • Microcarcinoma in young patients (used cautiously)
  • BMI < 30

Contraindications to RAT

  • Obesity (BMI > 30)
  • Degenerative shoulder pathology
  • ASA category > 2 (significant comorbidity)
  • Cancer (other than microcarcinoma in the young)
  • Graves' disease
  • Large cystic nodules > 6 cm (though aspiration at time of surgery can make some suitable)

The RAT Operation - Step-by-Step

Pre-operative Preparation

  1. No lines, BP cuffs, or ECG leads on the arm of the operative side
  2. Laryngeal nerve monitoring used routinely
  3. Mark the axillary incision (5-6 cm) while the patient is awake with the back of the hand touching the central forehead ("extended salute" position) - the only technique that identifies the best incision site
  4. Infiltrate incision site with 2% Xylocaine + 1:200,000 adrenaline

Patient Positioning

  • Supine, head on pillow (NOT on shoulder roll - avoids overextending neck and moving superior pole away from robotic instruments)
  • "Sniffing the morning air" position (subtle sniff position)
  • Head of table dropped by ~20 degrees to widen angle between arm and chest
  • Arm abducted and flexed with forearm pronated, back of hand resting on central portion of forehead - elevates and externally rotates the clavicle, shortening the distance from the incision to the thyroid gland

Cart Positioning (Docking)

  • Cart placed opposite side of the operating table from the incision
  • Docked at right angles to the operating table
  • All four arms can be placed through a single axillary incision, OR the fourth arm through a periareolar incision (scar invisible once healed)

Preparation of Robotic Field (Flap Dissection)

The area dissected is trapezoid-shaped, from thyroid cartilage to sternal notch in a subcutaneous plane. Dissection proceeds:
  1. Medially in subfascial and subcutaneous planes above pectoralis major and over the clavicle
  2. Natural dehiscence between sternal and clavicular heads of sternomastoid is entered
  3. Access the plane of strap muscles
  4. Under the strap muscles to access the thyroid gland
  5. Sternothyroid muscle lower insertion into manubrium/first rib is divided, as is its superior attachment to thyroid cartilage - gives full access to superior pole
  6. Omohyoid muscle routinely divided as it extends over the internal jugular vein
  7. Strap muscles separated off the thyroid gland to ~1/3 of contralateral lobe
  8. Modified retractor (Chung, Kuppersmith, Modena, or Imperial) inserted - then robot docked

Robotic Dissection

  • 30-degree down 12 mm stereoscopic endoscope placed at 220 degrees, inserted low laterally, extending high and upward medially toward the thyroid
  • Fourth arm (Prograsp 8 mm) - assistant/retractor role
  • First and third arms carry: Maryland forceps, Debakey forceps, Harmonic shears
  • Identify RLN and parathyroids first using Maryland and Debakey forceps
  • Once clearly defined, swap Debakey for Harmonic shears for haemostasis and dissection
Robotic transaxillary thyroidectomy - operative steps using da Vinci SP system
Intraoperative views of robotic transaxillary thyroidectomy: initial skin flap creation, SCM dissection, exposure of thyroid under strap muscles

Safety and Complications of RAT

Meta-analysis evidence (Scott-Brown's):
  • Cord palsy and hypocalcaemia rates no different from conventional thyroidectomy
  • However: low degree of freedom, high heterogeneity, heavy weighting from Korean pioneering units, publication bias (complications of RAT tend not to get published)
Additional RAT-specific risk:
  • Brachial plexus dysfunction (from arm positioning) - unique to RAT, absent in conventional thyroidectomy
  • Note: Chung's original method had arm fully extended over the head - this puts the brachial plexus at risk; Tolley modified this with the "hand on forehead" position
Airway obstruction from bleed:
  • Counterintuitively, less of a concern in RAT than conventional thyroidectomy - because the potential space for a haematoma to disseminate is far larger (the subfascial chest wall dissection space), so it cannot compress the airway as in conventional neck surgery
Operative time: Longer than conventional thyroidectomy (same inpatient stay and recovery)

Why RAT is Less Common in the West vs. Korea

Three factors created the "perfect environment" for RAT in Korea:
  1. Thyroid screening programmes - detecting small volume pathology early
  2. Reimbursement tariff for robotic vs. conventional surgery = 5:1 differential (economic incentive)
  3. National psyche for avoiding neck scars (feng shui cultural belief)
In Western Europe: different body habitus, different cultural attitudes to neck scars, different healthcare funding - making widespread adoption challenging.

Evidence Base Summary - RAT

  • Further prospective cohort studies are required before general conclusions can be made
  • Currently considered an evaluation phase technology for thyroid surgery
  • Mean tumour size excised in Korean series: 8 mm (microcarcinoma category) - caution extrapolating safety data to larger pathology
  • RAT is safe for hemithyroidectomy, lobectomy, total thyroidectomy, and level VI central compartment dissection; increasingly extended to lateral compartment neck dissection through the axillary approach

QUICK COMPARISON TABLE

FeatureMIVAT (Miccoli)Henry TechniqueRAT (Transaxillary)
Incision siteNeck (2-3 cm midline)Neck (lateral ports)Axilla (5-6 cm)
Neck scarYes (smaller)Yes (port scars)No neck scar
Gas insufflationNo (gasless)Yes (CO2, 8 mmHg)No (gasless)
Max nodule size3 cm3 cm4-6 cm
Total thyroidectomyPossibleNot possiblePossible
3D visionNo (2D endoscope)No (2D)Yes (3D stereo)
Degrees of freedomLimited (2D)Limited7 (wristed instruments)
Learning curve>50 casesVery steepVery steep
Additional risksScar hypertrophyHypercarbiaBrachial plexus injury
Adoption (UK)Very limitedVery rareNiche/specialist centres
PioneerMiccoli, PisaHenry, MarseilleChung, Yonsei/Tolley, UK

Sources: Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol 1 - Chapter 69 (Tolley); Cummings Otolaryngology Head and Neck Surgery - Chapter 122; Bailey & Love's Short Practice of Surgery 28th Ed. - Chapter 55
This is a shared conversation. Sign in to Orris to start your own chat.